| - SMTL ID
- 5zab.1
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.2
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.3
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.4
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.5
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.6
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.7
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.8
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.9
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.10
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.11
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.12
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.13
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.14
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.15
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 5zab.16
- Ligands
- (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|